• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M
Blockchain Set to Transform Wall Street by 2024

Blockchain Set to Transform Wall Street by 2024

user avatar

by Gustavo Mendoza

2 hours ago


As the financial landscape evolves, blockchain technology is poised to play a crucial role in the operations of Wall Street. Tom Lee, a prominent figure in the crypto space, predicts that 2024 will be a landmark year for the adoption of blockchain as a settlement layer in traditional finance, as enthusiastically stated in the publication.

Enhanced Transaction Efficiency

Lee emphasizes that the integration of blockchain technology will lead to enhanced transaction efficiency, enabling near-instantaneous settlements. This advancement is expected to significantly mitigate counterparty risk, a critical concern in financial transactions.

Commitment from Financial Institutions

Major financial institutions are already in the process of testing blockchain settlement systems, showcasing a strong commitment to incorporating this innovative technology into their operations. This shift not only highlights the growing acceptance of blockchain in mainstream finance but also signals a transformative change in how transactions are conducted on Wall Street.

InterLink Labs recently unveiled its strategic roadmap for 2026, focusing on launching a private mainnet and enhancing developer support, which contrasts with the ongoing blockchain adoption in traditional finance. For more details, see read more.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.